Company news

ReNerve Limited news in 2025

ReNerve Limited's news releases, calls and decks from 2025, newest first.

View company

ReNerve AGM Presentation

November 26, 2025

ReNerve completes $3.2m capital raising

November 19, 2025

Trading Halt

November 17, 2025

Nerve Cuff approved for use in US DoD and VA hospitals

November 12, 2025

ReNerve Clinical Study Expansion

November 4, 2025

Q1 FY26 Activities Report and Appendix 4C

October 22, 2025

ReNerve achieves first sales of amniotic tissue range

October 13, 2025

Investor Roadshow Presentation

September 28, 2025

Empliq Product Launch

September 22, 2025

ReNerve launches the EmpliQ product ranges

September 22, 2025

ReNerve - Appendix 4E

August 28, 2025

ReNerve records first sale of deep dermal product range

August 17, 2025

Q4 FY25 Activities Report and Appendix 4C

July 30, 2025

Expands Product Portfolio with Berkley partnership / Webinar

June 1, 2025

ReNerve receives market approval in Bahrain

May 28, 2025

ReNerve - Q3 FY25 Activities Report & Appendix 4C

April 29, 2025

Expands Global Footprint with Strategic Partnership in India

April 9, 2025

Response to ASX Aware Letter

March 31, 2025

Clinical Outcome Demonstrates Material Benefits for Patients

March 27, 2025

1HFY25 Results Announcement

February 27, 2025

1HFY25 Appendix 4D and Half Year Report

February 27, 2025

ReNerve - Q2 FY25 Activities Report & Appendix 4C

January 28, 2025

Decks in 2025